DNA Methylation of Combined Gene Markers in Cytological Specimens for Endometrial Cancer Screening
Diagnostic Cytopathology · 2026
DOI: 10.1002/dc.70081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostic Cytopathology, 2026. Verfasst von Mengjun Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Zhuji People's Hospital of Zhejiang Province, Zhuji, China. Hauptthemen laut MEDLINE: Endometrial Neoplasms, DNA Methylation, Biomarkers, Tumor, Early Detection of Cancer. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Introduction
Endometrial cancer (EC) is one of the most common gynecological cancers worldwide, with a rising incidence that highlights the urgent need for effective screening methods. Despite early‐stage diagnosis and favorable survival rates, current screening methods such as transvaginal ultrasonography lack specificity, often necessitating invasive procedures and revealing a significant gap in EC detection.
Methods
We conducted a comprehensive analysis of DNA methylation in cytological specimens as a biomarker for EC screening. Using a literature review and the UALCAN and Wanderer databases, we identified 7 hypermethylated genes associated with EC. Endometrial samples were collected from 300 women, and endometrial cytology testing (ECT) and quantitative methylation‐specific PCR (qMSP) were used to evaluate these genes. An XGBoost algorithm‐based model was developed to predict EC using DNA methylation data, with performance assessed through sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC).
Results
The methylation levels of HTR1B , CELF4 , and TBX5 were significantly elevated in EC and atypical hyperplasia compared to benign samples. The diagnostic model combining these genes demonstrated superior performance, achieving 97% sensitivity and an accuracy of 90%. SHAP value analysis indicated that TBX5 (1.079), HTR1B (0.990), and CELF4 (0.712) positively influenced the model's predictive power, with weights for TBX5 and HTR1B being similar but higher than that of CELF4 .
Conclusion
Integrating DNA methylation markers into ECT offers a non‐invasive and highly accurate approach to EC screening. This model's high diagnostic accuracy and reliability have the potential to transform EC diagnosis, reducing reliance on invasive procedures and improving clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Zhuji People's Hospital of Zhejiang Province, Zhuji, China.
- Medical Affairs Department, Guangzhou LBP Medicine Science & Technology Co., Ltd., Guangzhou, China.
- Department of Gynaecology and Obstetrics, Zhuji People's Hospital of Zhejiang Province, Zhuji, China.
ORCID-Profile: Siqi Wang, Hanmei Wang
Zitieren
APA
Hu, M., Kang, L., Huang, L., Wang, S., Wu, H., Bian, Y., He, L., & Wang, H. (2026). DNA Methylation of Combined Gene Markers in Cytological Specimens for Endometrial Cancer Screening. Diagnostic Cytopathology. https://doi.org/10.1002/dc.70081
Vancouver
Hu M, Kang L, Huang L, Wang S, Wu H, Bian Y, et al. DNA Methylation of Combined Gene Markers in Cytological Specimens for Endometrial Cancer Screening. Diagnostic Cytopathology. 2026. doi:10.1002/dc.70081
BibTeX
@article{Hu2026,
author = {Hu, Mengjun and Kang, Ling and Huang, Liujing and Wang, Siqi and Wu, Hangfei and Bian, Yuehuan and He, Liqun and Wang, Hanmei},
title = {DNA Methylation of Combined Gene Markers in Cytological Specimens for Endometrial Cancer Screening},
journal = {Diagnostic Cytopathology},
year = {2026},
doi = {10.1002/dc.70081}
}
EUVIMED